Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Opexa Therapeutics Inc (NASDAQ:OPXA)

0.77
Delayed Data
As of Mar 24
 -0.0421 / -5.18%
Today’s Change
0.50
Today|||52-Week Range
4.93
-16.30%
Year-to-Date
No recent news for Opexa Therapeutics Inc.

Today’s Trading

Previous close0.81
Today’s open0.80
Day’s range0.75 - 0.80
Volume134,363
Average volume (3 months)991,537
Market cap$5.5M
Dividend yield--
Data as of 3:59pm ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)+52.55%
Earnings growth (this year)+44.88%
Earnings growth (next 5 years)--
Revenue growth (last year)+100.99%
P/E ratioNM
Price/Sales6.34
Price/Book0.56

Competitors

 Today’s
change
Today’s
% change
CBIOCatalyst Biosciences...+0.44+9.24%
BSPMBiostar Pharmaceutic...-0.03-1.33%
SSKNSTRATA Skin Sciences...0.000.00%
--VANC Pharmaceuticals...+0.03+13.95%
Data as of 3:59pm ET, 03/24/2017

Financials

Next reporting dateMarch 27, 2017
EPS forecast (this quarter)-$0.24
Annual revenue (last year)$2.6M
Annual profit (last year)-$12.0M
Net profit margin-470.18%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer, CFO &
Director
Neil K. Warma
Corporate headquarters
The Woodlands, Texas

Forecasts


Search for Jobs